Emmanuel Sendaula
ID: UNCST-2020-R014767
|
A Stepped-Wedge Evaluation of an Integrated Maternal and Newborn Health Model for Pastoralist Communities in Karamoja, Uganda
REFNo: HS7225ES
Assess the effectiveness, feasibility, acceptability, fidelity, equity, and scalability of the integrated intervention using a stepped-wedge design.,Improve birth preparedness, early care-seeking, and timely referral through participatory women’s groups and community-managed emergency transport.,Strengthen emergency maternal and newborn care capacity among health workers, Village Health Teams, and Traditional Birth Attendants through simulation-based Helping Babies Breathe and Helping Mothers Survive training and continuous mentorship.,To evaluate the effectiveness and implementation of an integrated maternal and newborn health model aimed at reducing preventable maternal and newborn morbidity and mortality in the pastoralist districts of Moroto and Napak.,
|
Uganda |
2026-04-10 18:29:56 |
2029-04-10 |
Medical and Health Sciences |
|
Non-degree Award |
|
Ibrahim Twinomujuni
ID: UNCST-2024-R001873
|
Facilitators and barriers for enrollment of Non-suppressing Children and Adolescents living with HIV into Integrated Community Service Delivery Model (ICSDM) and its treatment outcomes in rural public HIV clinics – East central region Uganda.
REFNo: HS7088ES
To determine enrollment, retention, viral load suppression, and associated factors among non -suppressing CALHIV enrolled on ICSDM in rural public HIV clinics between October 2023 to date.
To explore facilitators and barriers to enrollment of non-suppressing CALHIV into the ICSDM in rural public HIV clinics between October 2023 to date
|
Uganda |
2026-04-10 18:28:02 |
2029-04-10 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Ibrahim Ali Fauzi
ID: UNCST-2022-R010478
|
Assessing Snakebite Envenoming in Rural Gulu, Uganda: Prevalence, Impact, and Climate Change Implications
REFNo: HS7325ES
Main Objective: To determine the burden and prevalence of SBE and to determine the extent of community understanding and awareness regarding climate change as a potential driver of snakebite incidence in rural Gulu District, Uganda
Specific Objectives:
1. To determine the prevalence and health outcomes of SBE in rural Gulu District.
2. To determine the burden associated with SBE at the individual and community level.
3. To determine community knowledge, attitudes, and awareness regarding SBE and climate change as a potential driver of its incidence.
|
Uganda |
2026-04-10 18:26:00 |
2029-04-10 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
BONIFACE OJOK
ID: UNCST-2023-R006075
|
Youth Futures: Youth-led initiatives for gender justice & peacebuilding in Uganda
REFNo: SS5048ES
4.4. General Objective
The general objective of the Youth Futures project is to use video documentation and participatory video approaches to identify, document, assess, and amplify the needs of children born of war in the Acholi sub-region, and to provide them with necessary livelihood skills in filmmaking, knowledge production, and advocacy.
4.5. Specific Objectives
The specific objectives of the project are:
1. To document and analyze the experiences of children born of war in the Acholi sub-region, including their challenges, needs, and aspirations.
2. To assess the impact of humanitarian, health, and education interventions on the well-being of children born of war in the Acholi sub-region.
3. To enhance youth engagement in research and peacebuilding processes, promoting the participation and empowerment of children born of war.
4. To provide livelihood skills in filmmaking, knowledge production, and advocacy to youth participants, enabling them to become agents of change in their communities.
|
Uganda |
2026-04-10 18:24:09 |
2029-04-10 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Paul Lobe
ID: UNCST-2025-R022156
|
UNSYSTEMATIC RISK FACTORS, AUDIT COMMITTEE EFFECTIVENESS AND FINANCIAL PERFORMANCE OF COMMERCIAL BANKS IN UGANDA
REFNo: SS4998ES
1-To establish the effect of credit risk on the financial performance of commercial banks in Uganda
2-To examine the effect of liquidity risk on the financial performance of commercial banks in Uganda
3-To determine the effect of operational risk on the financial performance of Commercial banks in Uganda
4a. To investigate the moderating effect of audit committee effectiveness on the relationship between credit risk and the financial performance of commercial banks in Uganda
4b. To determine the moderating effect of audit committee effectiveness on the relationship between liquidity risk and the financial performance of commercial banks in Uganda
4c. To examine the moderating effect of audit committee effectiveness on the relationship between Operational risk and the financial performance of commercial banks in Uganda
|
Uganda |
2026-04-10 18:21:31 |
2029-04-10 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Daniel Emoru Reagan
ID: UNCST-2025-R020048
|
Adaptation and Validation of the Pictorial Fit-Frail Scale Among Older Persons Living with HIV At the Infectious Disease Institute, Kampala.
REFNo: HS7239ES
General Objective: To culturally adapt and validate the standard Pictorial Fit-Frail Scale(self-assessment) against the Fried Frailty Phenotype Scale for frailty screening among OPLWH aged ≥50 years at the Infectious Disease Institute, Kampala.
Specific Objectives
To culturally adapt and validate the standard Pictorial Fit-Frail Scale(self-assessment) against the Fried Frailty Phenotype Scale for frailty screening among OPLWH aged ≥50 years at the Infectious Disease Institute, Kampala.
1.4.2. SPECIFIC OBJECTIVES
(i) To culturally adapt the PFFS among OPLWH aged ≥ 50 years at the infectious disease institute, Kampala, by assessing comprehension of its 14 pictorial domains and modifying images as needed for the Ugandan context.
(ii) To determine the diagnostic validity of the PFFS compared to FFP scale for frailty screening among OPLWH aged ≥50 years at the Infectious Disease Institute, Kampala.
(iii) To determine the level of agreement between frailty classifications obtained using the PFFS and FFP among OPLWH aged ≥50 years at the Infectious Disease Institute, Kampala.
|
Uganda |
2026-04-10 18:20:22 |
2029-04-10 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
|
John Mugwanya Mulo
ID: UNCST-2026-R023496
|
Digital Media and Malaria Vaccine: Perceptions of Parents with Children Under Five in Wakiso and Karenga Districts, in Uganda
REFNo: SS5060ES
In general, the research will understand the perceptions of parents with children under five years of age on the influence of digital media on the uptake of the malaria vaccine in Wakiso and Karenga Districts. Specifically, it will: explore how parents of children under five in Wakiso and Karenga Districts in Uganda perceive the influence of digital media on malaria vaccine acceptance, identify barriers and facilitators to malaria vaccine uptake shaped by digital media exposure and develop qualitative insights and recommendations for leveraging trusted digital media channels to enhance malaria vaccine uptake, complementing interventions like vector control, case management, chemoprevention and surveillance.
|
Uganda |
2026-04-10 18:17:56 |
2029-04-10 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
William Worodria Ofuti
ID: UNCST-2022-R010915
|
Program for Rifampicin-Resistant Disease with Stratified Medicine for TB” (PRISM-TB)
REFNo: HS7398ES
To identify, among participants with fluoroquinolone-susceptible multidrug-resistant/rifampicin-resistant tuberculosis (FQ-S MDR/RR-TB), the preferred BPaLM strategy of 13 or 17 weeks for participants stratified to receive shorter treatment and 17 or 24 weeks for participants stratified to receive longer treatment, as defined by a prespecified stratification algorithm, and to evaluate whether this BPaLM strategy has noninferior efficacy to the control strategy at Week 73.
1. To evaluate whether a BPaLM strategy of 17 weeks for participants stratified to receive shorter treatment and 24 weeks for participants stratified to receive longer treatment, as defined by a prespecified stratification algorithm, has superior DOOR probability to the control strategy combining efficacy at the end of follow-up (a minimum of 28 weeks post-randomization) and safety at 28 weeks post-randomization.
2. To evaluate whether a BPaLM strategy of 17 weeks for all participants has superior DOOR probability to the control strategy combining efficacy at the end of follow-up (a minimum of 28 weeks post-randomization) and safety at 28 weeks post-randomization.
3. To evaluate whether a BPaLM strategy of 13 weeks for participants stratified to receive shorter treatment and 24 weeks for participants stratified to receive longer treatment, as defined by a prespecified stratification algorithm, has superior DOOR probability to the control strategy combining efficacy at the end of follow-up (a minimum of 28 weeks post-randomization) and safety at 28 weeks post-randomization.
4. To evaluate whether a BPaLM strategy of 13 weeks for participants stratified to receive shorter treatment and 17 weeks for participants stratified to receive longer treatment, as defined by a prespecified stratification algorithm, has superior DOOR probability to the control strategy combining efficacy at the end of follow-up (a minimum of 28 weeks post-randomization) and safety at 28 weeks post-randomization.
5. To compare the proportion of participants who experience grade 3 or higher adverse events by Week 28 in the preferred BPaLM strategy to the control strategy.
6. To compare the proportion of participants who experience adverse events of special interest by Week 28 in the preferred BPaLM strategy to the control strategy.
7. To compare the proportion of participants who experience a TB-related unfavorable outcome at Week 73 on the preferred BPaLM strategy with the control strategy, among participants stratified to receive shorter treatment.
8. To compare the proportion of participants who experience a TB-related unfavorable outcome at Week 73 on the preferred BPaLM strategy with the control strategy, among participants stratified to receive longer treatment.
9. To evaluate the pharmacokinetics of all drugs in the BPaLM regimen with an additional focus on bedaquiline elimination (Stages 1 and 2).
10. To determine the dose-response and exposure-response relationships between study drug estimated PK parameters with efficacy and toxicity (Stages 1 and 2).
11. To evaluate the feasibility and acceptability of treatment stratification in the context of treatment for MDR/RR-TB from the participant and the health system perspective (Stages 1 and 2).
|
Uganda |
2026-04-10 18:15:27 |
2029-04-10 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
Kimuli NamyaloAngella
ID: UNCST-2025-R022072
|
PREVALENCE OF HELICOBACTER PYLORI, ASSOCIATED FACTORS AND MAGNITUDE OF RESISTANCE AGAINST FIRST LINE ANTIBIOTICS AMONG CHILDREN PRESENTING WITH GASTRO-INTESTINAL SYMPTOMS AT HOLY INNOCENTS CHILDREN’S HOSPITAL, SOUTHWESTERN UGANDA
REFNo: HS6980ES
1. To determine the prevalence of H. pylori infection among children aged 1-16 years at Holy Innocents Children’s Hospital, southwestern Uganda
2. To assess the factors associated with the presence of H. pylori among children presenting with gastrointestinal symptoms at Holy Innocents Children’s Hospital, Southwestern Uganda
3. To determine the proportion of H. pylori strains that possess resistance genes to Amoxicillin, metronidazole and clarithromycin among the children population at Holy Innocents Children’s Hospital, Southwestern Uganda
|
Uganda |
2026-04-10 18:12:39 |
2029-04-10 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
|
ASIPHAS OWARAGANISE
ID: UNCST-2026-R023544
|
Licensing Foreign Trained Doctors and Dentists in Uganda: Performance and Stakeholder Perspectives, 2015-2025.
REFNo: HS7299ES
Our overarching goal is to generate robust, mixed-methods evidence detailing trends, grades, and the perspectives of FTDs and their examiners to inform the professional council’s policies on licensure and workforce integration. Specifically, we will i) characterize the structural attributes and outcome performance of FTDs seeking licensure in Uganda, and ii) explore stakeholder experiences and perceptions of the medical licensure process for FTDs, situating findings within the context of evolving regional health workforce policies
|
Uganda |
2026-04-10 18:11:34 |
2029-04-10 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|